Search Results - "Klipping, Christine"

Ovulation-Inhibiting Effects of Dienogest in a Randomized, Dose-Controlled Pharmacodynamic Trial of Healthy Women by Klipping, Christine, Duijkers, Ingrid, Remmers, Ageeth, Faustmann, Thomas, Zurth, Christian, Klein, Stefan, Schuett, Barbara

“…Dienogest offers pharmacological advantages for the effective treatment of endometriosis and for use in contraception and hormone replacement therapy. This…”
Get full text

Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function by Gerrits, Mireille G.F., Pharm.D, Kramer, Hester, Ph.D, Galta, Rachid el, Ph.D, van Beerendonk, Geertje, Ph.D, Hanssen, Rob, Ph.D, Abd-Elaziz, Khalid, M.D, Klipping, Christine, M.D., Ph.D, Duijkers, Ingrid, M.D., Ph.D, Stoch, S. Aubrey, M.D

“…Objective To assess the safety, pharmacokinetics, and pharmacodynamics of MK-8389. Design Double-blind, placebo-controlled, parallel-group, ascending dose…”
Get full text

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women by Erb, K, Klipping, C, Duijkers, I, Pechstein, B, Schueler, A, Hermann, R

“…To investigate the pharmacodynamic effects and plasma pharmacokinetics of single subcutaneous doses of cetrorelix acetate in healthy premenopausal women. Phase…”
Get more information

Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone by Klipping, Christine, Duijkers, Ingrid, Mawet, Marie, Maillard, Catherine, Bastidas, Adriana, Jost, Maud, Foidart, Jean-Michel

“…To evaluate the effect on endocrine and metabolic parameters of a new combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP)…”
Get full text

Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function by Duijkers, Ingrid, Klipping, Christine, Kinet, Virginie, Jost, Maud, Bastidas, Adriana, Foidart, Jean-Michel

“…To evaluate the effects of estetrol 15 mg/drospirenone 3 mg on ovarian function. Single-center, randomized, open-label, parallel study in healthy young women…”
Get full text

Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters by Douxfils, Jonathan, Klipping, Christine, Duijkers, Ingrid, Kinet, Virginie, Mawet, Marie, Maillard, Catherine, Jost, Maud, Rosing, Jan, Foidart, Jean-Michel

“…To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC). In this randomized, single centre, open-label, exploratory study,…”
Get full text

Unintended drug exposure during pregnancy in clinical trials - a survey in early drug development by Erb-Zohar, Katharina, Sourgens, Hildegard, Breithaupt-Groegler, Kerstin, Klipping, Christine

“…To collect information on unintended drug exposure during pregnancy in early clinical drug development. Questionnaire mailed in autumn 2015 to members of human…”
Get full text

CHARACTERIZATION OF PITUITARY AND OVARIAN HORMONE CONCENTRATIONS DURING TREATMENT WITH RELUGOLIX COMBINATION THERAPY by Duijkers, Ingrid, Migoya, Elizabeth M., Arjona Ferreira, Juan Camilo, Klipping, Christine

Get full text

The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg by Banh, Camille, Rautenberg, Tanja, Duijkers, Ingrid, Borenzstein, Pascale, Monteil, Catherine, Levy-Gompel, Delphine, Klipping, Christine, Scherrer, Bruno, Glasier, Anna

“…Among combined oral contraception (COC) users, to determine the effect on ovarian activity and ovulation of waiting five days before restarting COC, versus…”
Get full text

A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials by Abd-Elaziz, Khalid, Duijkers, Ingrid, Stöckl, Lars, Dietrich, Bruno, Klipping, Christine, Eckert, Kelvin, Goletz, Steffen

“…Abstract STUDY QUESTION What are the differences and similarities of pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of the novel recombinant…”
Get full text

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen by Klipping, Christine, Duijkers, Ingrid, Trummer, Dietmar, Marr, Joachim

“…Abstract Background This study was conducted to compare ovarian activity of an oral contraceptive containing drospirenone (drsp) 3 mg plus ethinylestradiol…”
Get full text

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol by Kluft, Cornelis, Zimmerman, Yvette, Mawet, Marie, Klipping, Christine, Duijkers, Ingrid J.M, Neuteboom, Jacoline, Foidart, Jean-Michel, Bennink, Herjan Coelingh

“…Summary Objective The effects of estetrol (E4), a natural fetal estrogen, combined with drospirenone (DRSP) were evaluated on plasma levels of sex…”
Get full text

Ovulation inhibition with a new vaginal ring containing trimegestone by Duijkers, Ingrid J.M., Klipping, Christine, Draeger, Corinna, Schug, Barbara S., Dax, Annika, Friedrich, Maika, Nickisch, Klaus

“…The primary objective was to determine the lowest trimegestone (TMG) dose, administered via a vaginal ring, that effectively inhibited ovulation…”
Get full text

Ovulation Inhibition With A New Vaginal Ring Containing Trimegestone by Duijkers, Ingrid J. M., Klipping, Christine, Draeger, Corinna, Schug, Barbara S., Dax, Annika, Friedrich, Maika, Nickisch, Klaus

“…(Abstracted from Contraception 2020;102:237–242) Women receiving combined hormonal contraceptives (CHCs) are at increased risk of stroke, myocardial…”
Get full text

Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel by Duijkers, Ingrid J.M., Klipping, Christine, Rautenberg, Tanja, Schug, Barbara S., Kochhar, Prithi S., Osterwald, Hermann, Oettel, Michael

“…To investigate the effect of different oral dosages of levonorgestrel (LNG) on ovarian activity and to identify the lowest dosage at which no ovulation…”
Get full text

Hormonal contraceptive use lowers female intrasexual competition in pair-bonded women by Cobey, Kelly D, Klipping, Christine, Buunk, Abraham P

“…Abstract The purpose of this study was to test the influence of hormonal contraceptive use on levels of female intrasexual competition. Twenty-eight women…”
Get full text

A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea by Fox, Michelle C., Klipping, Christine, Nguyen, Allison Martin, Frenkl, Tara L., Cruz, Sandra M., Wang, Yinna, Korver, Tjeerd

“…To evaluate the effect of investigational vaginal rings containing nomegestrol acetate (NOMAC) plus 17β-estradiol (E2) or etonogestrel (ENG) plus E2 in women…”
Get full text

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel by Klipping, Christine, Duijkers, Ingrid, Parke, Susanne, Mellinger, Uwe, Serrani, Marco, Junge, Wolfgang

“…Background: A novel estradiol-based combined oral contraceptive (COC) is currently available in many countries worldwide, including Europe and the US. Based on…”
Get full text

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters by Klipping, Christine, Duijkers, Ingrid J M, Jost, Maud, Bastidas, Adriana, Foidart, Jean Michel F

“…Abstract Background: Most combined oral contraceptives (COCs) contain ethinylestradiol (EE), an estrogen component known to increase the risk of venous…”
Get full text

The Effect of Estetrol/Drospirenone on Ovarian Function Is Similar to a Well-Established Combined Oral Contraceptive: Results From a Phase 2 Study by Duijkers, Ingrid J M, Klipping, Christine, Jost, Maud, Bastidas, Adriana, Foidart, Jean Michel F

“…Abstract Background: Combined oral contraceptives (COCs) often contain ethinylestradiol (EE), an estrogen known to be associated with several side effects…”
Get full text